[HTML][HTML] Anticoagulation Strategies during ECMO Application
H Oğuş, E Altınay, MK Kırali - 2024 - intechopen.com
During ECMO support, optimal anticoagulant drugs, dosing charts, ideal anticoagulation
levels, and monitoring parameters have not yet been definitively established, despite the …
levels, and monitoring parameters have not yet been definitively established, despite the …
Bivalirudin in Extracorporeal Membrane Oxygenation
S Dunham, PM Wieruszewski… - Journal of Cardiovascular …, 2022 - journals.lww.com
Extracorporeal membrane oxygenation (ECMO) is a mechanical support treatment modality
utilized in patients with refractory cardiac and/or pulmonary failure. Bleeding and thrombotic …
utilized in patients with refractory cardiac and/or pulmonary failure. Bleeding and thrombotic …
[PDF][PDF] CURRENT STATE OF ORAL ANTICOAGULANT USE (DABIGATRAN, RIVAROXABAN, APIXABAN) IN THERAPEUTIC PRACTICE: A
YO Byrka, OO Babicheva, VL Prokhorenko… - The 9 th International …, 2024 - sci-conf.com.ua
Aim. To investigate the current status of DOAC utilization, their advantages, and
disadvantages. Materials and methods. Analytical review and analysis of scientific literature …
disadvantages. Materials and methods. Analytical review and analysis of scientific literature …